Tech Company Financing Transactions
Persephone Biosciences Funding Round
Persephone Biosciences, based in San Diego, secured $15 million in investment from BrightEdge, Fifty Years and Pioneer Fund.
Transaction Overview
Company Name
Announced On
7/19/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to advance the ARGONAUT trial (NCT04638751), the largest study ever conducted in the U.S. to identify biomarkers for cancer treatment and prevention by mapping the gut-immune axis.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Persephone Biosciences, a San Diego, CA-based synthetic biology company. We are a group of people thinking about a better future for health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephanie Culler
Chief Technical Officer
Steve Van Dien
Browse more venture capital transactions:
Prev: 7/18/2022: ForSight Robotics venture capital transaction
Next: 7/19/2022: Charter Works venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs